Vallon Pharmaceuticals focuses on the development and commercialization of novel treatments for CNS disorders. We are currently focused on the development and commercialization of a novel treatment for ADHD and Narcolepsy where there is substantial unmet need. Vallon began conducting clinical trials of ADAIR in mid-2018. If clinical trials are successful, Vallon will seek marketing approval for the product from national regula...
Vallon Pharmaceuticals focuses on the development and commercialization of novel treatments for CNS disorders. We are currently focused on the development and commercialization of a novel treatment for ADHD and Narcolepsy where there is substantial unmet need. Vallon began conducting clinical trials of ADAIR in mid-2018. If clinical trials are successful, Vallon will seek marketing approval for the product from national regulatory bodies including the FDA. Vallon intends to develop multiple products using its patented abuse deterrent technology.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.